- Current report filing (8-K)
January 28 2010 - 1:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of earliest event reported):
January 28,
2010
NUTRACEUTICAL
INTERNATIONAL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
|
|
000-23731
|
|
87-0515089
|
(State of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
1400 Kearns Boulevard, 2
nd
Floor
Park City, Utah
(Address of principal executive offices)
|
|
84060
(Zip Code)
|
Registrants telephone number, including area code:
(435) 655-6106
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see
General Instruction A.2. below):
o
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On January 28,
2010, Nutraceutical International Corporation reported results for the fiscal
2010 first quarter ended December 31, 2009. The press release reporting the results is
attached to this Form 8-K as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
Exhibits.
99.1
Press release issued by Nutraceutical
dated January 28, 2010.
This Form 8-K
and the attached Exhibit are furnished to comply with Item 2.02 and Item
9.01 of Form 8-K. Neither this Form 8-K
nor the attached Exhibit are to be deemed filed for purposes of Section 18
of the Securities Exchange Act of 1934, nor shall this Form 8-K nor the
attached Exhibit be deemed incorporated by reference in any filing under
the Securities Act of 1933 (except as shall be expressly set forth by specific
reference in such filing).
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
NUTRACEUTICAL INTERNATIONAL CORPORATION
(Registrant)
|
|
|
|
|
Date: January 28,
2010
|
By:
|
/s/
Cory J. McQueen
|
|
|
Cory J. McQueen
|
|
|
Vice President and Chief
Financial Officer
|
|
|
(Principal Financial and
Accounting Officer)
|
2
EXHIBIT
INDEX
Exhibit Number
|
|
Description
|
|
|
|
99.1
|
|
Press release issued by Nutraceutical dated
January 28, 2010.
|
3
Nutraceutical International Corp. (MM) (NASDAQ:NUTR)
Historical Stock Chart
From Apr 2024 to May 2024
Nutraceutical International Corp. (MM) (NASDAQ:NUTR)
Historical Stock Chart
From May 2023 to May 2024